Clinical trial

Glycine to Treat Psychotic Disorders in Children

NCT00005658

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-05-01

PhasePHASE2

Study timeline

Study start (unknown)2000-05-01Date precision: month

Registry last updated2008-03-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psychotic Disorderunresolved

Schizoaffecitve Disorderunresolved

Schizophreniaunresolved

Interventions

GlycineDRUG · verified · RxNorm: glycine

Sponsors & collaborators

National Institute of Mental Health (NIMH)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00005658 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.